Call For Abstract Primary Presenter

Thank you for your interest in submitting an abstract for consideration as a presentation at the 2026 ASKP3 Annual Conference on January 29-31, in Austin, TX.

The ASKP3 Annual Conference is designed to provide a variety of educational topics that will advance the safe and ethical use of ketamine to treat mental health disorders and pain conditions.

In order to be considered, please complete your submission no later than 11:59 p.m. ET on Monday, June 30, 2025.

Submissions will be reviewed only if all required components are submitted before the submission close date.

Please ensure that all co-presenter information—including full contact details, professional designations, CVs, headshots, and bios—is submitted along with your abstract proposal to complete the submission process.

Question Title

* 1. Primary Presenter Full Name (include designations)

Question Title

* 2. Primary Presenter Organization Name

Question Title

* 3. Primary Presenter Title

Question Title

* 4. Primary Presenter Email

Question Title

* 5. Primary Presenter Phone

Question Title

* 6. Target Audience (Check all that apply)

Question Title

* 7. Type of Presentation

Question Title

* 8. Presentation Title (100 character limit)

Question Title

* 9. Brief description (100 word limit)

Question Title

* 10. Link to publication (if data is published)

Question Title

* 11. Please list three (3) measurable learning objectives for your proposed session.

Your learning objectives should clearly describe what participants will be able to do after attending your session. Objectives must be written using action verbs that reflect observable and measurable outcomes, in alignment with AANA Continuing Education (CE) credit guidelines.

Avoid vague terms like “understand” or “learn” and instead use specific, action verbs such as:

Identify
Describe
Demonstrate
Apply
Evaluate
Compare
Analyze

Example: "Evaluate the clinical protocols and safety considerations involved in the implementation of ketamine infusion therapy for treatment-resistant depression."

Question Title

* 12. Abstract Summary (500-word limit)

Question Title

* 13. Primary Presenter CV/Resume

PDF, DOC, DOCX file types only.
Choose File

Question Title

* 14. Primary Presenter Headshot

PNG, JPG, JPEG file types only.
Choose File

Question Title

* 15. Snapshot Introduction Bio: Please provide a short introduction of the primary presenter (in third person) for credit approval and for use by the session moderator (LIMITED TO 150 CHARACTERS). Highlight your work and industry-related experience.

Question Title

* 16. Do you have co-presenters? (Please note Co-Presenter information MUST be completed before you submit your abstract)

T